University of Pittsburgh at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
University of Pittsburgh brings 16 presentations to SABCS 2026 in San Antonio. The university presents MUC1 vaccine trials in DCIS, lobular cancer subtyping, recurrence patterns in HR-positive disease and immune receptor repertoires.
| Organization | SABCS 2026 Attendance |
|---|---|
University of Pittsburgh Pittsburgh, PA | |
A public research university with a medical school and cancer research programs. | Talk Tue Dec 8 11:50am–12:15pm Talk Wed Dec 9 7:33–7:36am Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Talk Thu Dec 10 8:06–8:09am Talk Thu Dec 10 8:06–8:09am Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm |
Find decision makers at University of Pittsburgh
Tell us what you sell and we’ll find the people at University of Pittsburgh most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction